d-alpha tocopherol has been researched along with Long QT Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, MMS; Branco de Barros, AL; Cassali, GD; de Oliveira, RB; Fernandes, C; Fernandes, RS; Ferreira, LAM; Lages, EB; Paiyabhroma, N; Richard, S; Sicard, P | 1 |
| Lu, Y; Sun, X; Wang, J; Wang, Z; Yang, B; Zhang, Y | 1 |
| Han, H; Wang, H; Wang, J; Wang, Z; Yang, B; Zhang, Y | 1 |
3 other study(ies) available for d-alpha tocopherol and Long QT Syndrome
| Article | Year |
|---|---|
pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
Topics: alpha-Tocopherol; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Docosahexaenoic Acids; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Hydrazones; Hydrogen-Ion Concentration; Lipids; Long QT Syndrome; Mice; Mice, Inbred BALB C; Nanostructures; Neoplasm Transplantation; Prodrugs; Ventricular Function, Left | 2021 |
Potential therapeutic value of antioxidants for abnormal prolongation of QT interval and the associated arrhythmias in a rabbit model of diabetes.
Topics: Action Potentials; Animals; Antioxidants; Arrhythmias, Cardiac; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Male; Myocytes, Cardiac; Oxidative Stress; Potassium Channels, Inwardly Rectifying; Rabbits; Reactive Oxygen Species; Vitamin E | 2011 |
Impairment of human ether-à-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms.
Topics: Adenosine Triphosphate; Cation Transport Proteins; Cells, Cultured; DNA-Binding Proteins; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glucose; Glycolysis; Humans; Hyperglycemia; Hypoglycemia; Long QT Syndrome; Oxidative Phosphorylation; Phenotype; Phosphorylation; Potassium Channels; Potassium Channels, Voltage-Gated; Reactive Oxygen Species; Sodium Cyanide; Trans-Activators; Transcriptional Regulator ERG; Vitamin E | 2003 |